论区域城镇体系发展中的城市政府作用

在经济全球化的形势下,区域的经济竞争与合作日益加强,城市治理模式也随之发生变化。为了适应我国区域经济重组和城镇体系发展的新趋势,城市治理模式应向多元政府与其他组织构成的管治联盟转变,形成新的公共治理模式。城市政府的主要作用体现在战略规划与协调、制定市场规制与监督、城市理财与经营以及合理提供城市服务等方面。     

Are we there yet? Best practices for diversity and inclusion in Australia

ABSTRACT

This article reports on the findings of a pilot research project investigating current best practices, operating within national law firms in Australia, that support women lawyers in their advancement to partnership and other leadership positions. Academic research and professional body reports suggest that current diversity and inclusion (D&I) initiatives across the private sector are not resulting in significant change to advancement, retention and attrition of women in the legal profession. However, work done by the Women Lawyers’ Association of New South Wales in Australia, through the Data Comparison Project (DCP), indicates that some firms have made better progress than others. Building on the DCP, this article presents the findings of a pilot project involving in-depth interviews with four of the top-achieving national law firms in Australia on gender equity criteria. It finds that these firms are collectively engaging with many of the best practice initiatives for D&I recommended by the current national and international research and scholarship, and in some instances go beyond international best practice. What is apparent, however, is that the current best practices have yet to achieve significant advancement of women, or to break through the glass ceilings that continue to operate for women in large Australian law firms.     

论道德建设的三个实践维度

现代社会道德文化的创造和延续,需要必要的资源,而资源的最重要的一个方面是来自于社会道德生活世界的实践创造和经验积累。鉴于此,道德建设的实践归宿是回归日常生活,道德建设的实践方式应重视道德践履,道德建设的实践保障要依靠制度支撑。     

中国经济体制改革与劳动合同制的发展

任何劳动用工形式都是由当时的经济体制决定并随之而发展的.从劳动用工终身制到合同制,再从<劳动法>到<劳动合同法>,改革开放后中国的劳动用工形式发生了重大改变.<劳动合同法>颁布后各界反应不一,只有将此过程同三十年来中国经济体制转型的大背景相结合,才能从根本上理解中国劳动合同制产生、发展和规范的历史脉络,也才能从根本上理解<劳动合同法>.     

Diffusing information

His many publications include Theories of Mass Communication; Understanding Mass Communication; Milestones in Mass Communication Research;and, with Otto N. Larsen, The Flow of Information.     

Plasma,oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions

In a double-blind placebo controlled study on psychomotor skills important for car driving (Study 1), a 75 mg dose of +/- 3,4-methylenedioxymethamphetamine (MDMA) was administered orally to 12 healthy volunteers who were known to be recreational MDMA-users. Toxicokinetic data were gathered by analysis of blood, urine, oral fluid and sweat wipes collected during the first 5h after administration. Resultant plasma concentrations varied from 21 to 295 ng/ml, with an average peak concentration of 178 ng/ml observed between 2 and 4h after administration. MDA concentrations never exceeded 20 ng/ml. Corresponding MDMA concentrations in oral fluid, as measured with a specific LC-MS/MS method (which required only 50 microl of oral fluid), generally exceeded those in plasma and peaked at an average concentration of 1215 ng/ml. A substantial intra- and inter-subject variability was observed with this matrix, and values ranged from 50 to 6982 ng/ml MDMA. Somewhat surprisingly, even 4-5h after ingestion, the MDMA levels in sweat only averaged 25 ng/wipe. In addition to this controlled study, data were collected from 19 MDMA-users who participated in a driving simulator study (Study 2), comparing sober non-drug conditions with MDMA-only and multiple drug use conditions. In this particular study, urine samples were used for general drug screening and oral fluid was collected as an alternative to blood sampling. Analysis of oral fluid samples by LC-MS/MS revealed an average MDMA/MDEA concentration of 1121 ng/ml in the MDMA-only condition, with large inter-subject variability. This was also the case in the multiple drug condition, where generally, significantly higher concentrations of MDMA, MDEA and/or amphetamine were detected in the oral fluid samples. Urine screening revealed the presence of combinations such as MDMA, MDEA, amph, cannabis, cocaine, LSD and psilocine in the multiple-drug condition.